These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7910189)

  • 21. Ability of M. leprae, Mycobacterium w, and ICRC bacillus to produce macrophage activating factors from lymphocytes of leprosy patients.
    Prasad HK; Singh AK; Talwar GP
    Lepr India; 1978 Oct; 50(4):539-49. PubMed ID: 374871
    [No Abstract]   [Full Text] [Related]  

  • 22. The mouse footpad model.
    Draper P
    Lepr Rev; 2006 Mar; 77(1):3-4. PubMed ID: 16715685
    [No Abstract]   [Full Text] [Related]  

  • 23. 17th International Leprosy Congress, Hyderabad. Reports of pre-congress workshops held on January 29th-30th, 2008.
    Indian J Lepr; 2008; 80(2):211-29. PubMed ID: 19425514
    [No Abstract]   [Full Text] [Related]  

  • 24. Autochthonous Leprosy without Armadillo Exposure, Eastern United States.
    Rendini T; Levis W
    Emerg Infect Dis; 2017 Nov; 23(11):1928. PubMed ID: 29048282
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hydrolytic enzymes in macrophages from leprosy patients in presence of Mycobacterium leprae.
    Marolia J; Mahadevan PR
    Indian J Lepr; 1984; 56(4):776-83. PubMed ID: 6398340
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dosage and site of entry influence growth and dissemination of Mycobacterium leprae in T900r mice.
    Ebenezer GJ; Arumugam S; Job CK
    Int J Lepr Other Mycobact Dis; 2002 Dec; 70(4):245-9. PubMed ID: 12768925
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Leprosy in Nonimmigrant Canadian Man without Travel outside North America, 2014.
    Bonnar PE; Cunningham NP; Boggild AK; Walsh NM; Sharma R; Davis IRC
    Emerg Infect Dis; 2018 Jan; 24(1):165-166. PubMed ID: 29260666
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Animal transmission of mycobacterium leprae--experimental leprosy].
    Kohaska K
    Nihon Rai Gakkai Zasshi; 1990; 59(2):86-97. PubMed ID: 2133036
    [No Abstract]   [Full Text] [Related]  

  • 29. Use of non-conventional antigen: M. habana in detecting M. leprae antibodies from leprosy patients and contacts in FLA-ABS test.
    Rana NS; Gupta HP; Singh NB
    Indian J Lepr; 1988 Oct; 60(4):593-9. PubMed ID: 3075637
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Defective monocyte chemotaxis in active lepromatous leprosy.
    Schuller-Levis G; Harris D; Cutler E; Meeker HC; Haubenstock H; Levis WR
    Int J Lepr Other Mycobact Dis; 1987 Jun; 55(2):267-72. PubMed ID: 3298473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The mouse foot-pad technique for cultivation of Mycobacterium leprae.
    Levy L; Ji B
    Lepr Rev; 2006 Mar; 77(1):5-24. PubMed ID: 16715686
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term culture of multibacillary leprosy macrophages isolated from skin lesions: a new model to study Mycobacterium leprae-human cell interaction.
    Moura DF; Teles RM; Ribeiro-Carvalho MM; Teles RB; Santos IM; Ferreira H; Fulco TO; Nery JA; Sampaio EP; Sarno EN
    Br J Dermatol; 2007 Aug; 157(2):273-83. PubMed ID: 17553031
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Leprosy bacillus--possibly the first chemoautotrophic human pathogen cultivated in vitro and characterised.
    Chakrabarty AN; Dastidar SG; Sen A; Banerjee P; Roy R
    Indian J Exp Biol; 2001 Oct; 39(10):962-83. PubMed ID: 11883520
    [TBL] [Abstract][Full Text] [Related]  

  • 34. XIVth International Leprosy Congress. Orlando, Florida, 29 August-4 September 1993. Abstracts.
    Int J Lepr Other Mycobact Dis; 1993 Dec; 61(4 Suppl):1A-175A. PubMed ID: 7908686
    [No Abstract]   [Full Text] [Related]  

  • 35. Chimpanzees used for medical research shed light on the pathoetiology of leprosy.
    Suzuki K; Tanigawa K; Kawashima A; Miyamura T; Ishii N
    Future Microbiol; 2011 Oct; 6(10):1151-7. PubMed ID: 22004034
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Serodiagnostic monitoring of leprosy].
    Diachina MN
    Probl Tuberk Bolezn Legk; 2003; (11):32-9. PubMed ID: 14689796
    [No Abstract]   [Full Text] [Related]  

  • 37. Postgenomic Mycobacterium leprae antigens for cellular and serological diagnosis of M. leprae exposure, infection and leprosy disease.
    Geluk A; Duthie MS; Spencer JS
    Lepr Rev; 2011 Dec; 82(4):402-21. PubMed ID: 22439280
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A longitudinal study of immunologic reactivity in leprosy patients treated with immunotherapy.
    Rada E; Ulrich M; Aranzazu N; Santaella C; Gallinoto M; Centeno M; Rodriguez V; Convit J
    Int J Lepr Other Mycobact Dis; 1994 Dec; 62(4):552-8. PubMed ID: 7868953
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Importance of repeated immunological stimulation using BCG in the treatment of lepromatous leprosy. New evaluation of 13 patients].
    Ruscher H; Faye I; Languillon J; Sarrat H; Oudart JL; Carnus H
    Bull Soc Med Afr Noire Lang Fr; 1973; 18(4):470-6. PubMed ID: 4599200
    [No Abstract]   [Full Text] [Related]  

  • 40. Biomarkers for leprosy: would you prefer T (cells)?
    Geluk A
    Lepr Rev; 2013 Mar; 84(1):3-12. PubMed ID: 23741878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.